Literature DB >> 17322598

Evaluation of 19 cases of inadvertent globe perforation due to periocular injections.

Salil S Gadkari1.   

Abstract

BACKGROUND: Inadvertent globe perforation due to periocular injection is a serious iatrogenic complication. AIM: To study risk factors, management and visual outcome of inadvertent globe perforation during periocular injection, in cases referred to a tertiary eye care center. DESIGN AND
SETTING: Retrospective study at a tertiary referral center with a single investigator.
MATERIALS AND METHODS: Nineteen consecutive cases with a clinical diagnosis of globe perforation were studied (1998-2004). Clinical setting, risk factors, clinical presentation, management and visual outcome were analyzed.
RESULTS: Retrobulbar injections 6 (32%), peribulbar injections 10 (53%) and subconjunctival injections 3 (16%) were responsible for inadvertent globe perforation. Anesthetists accounted for 6 (32%) injections and 13 (69%) were referred from high volume community settings. Anesthetists identified the mishap on the table in 17% (1 out of 6) of cases and the ophthalmologists in 69% (9 out of 13) myopia was present in 10 (53%). Breaks were located inferotemporally in nine eyes. Four underwent laser and cryopexy, 14 (74%) underwent vitreous surgery. Visual acuity greater than 20/200 was achieved in 12 patients.
CONCLUSION: Myopia was found to be a significant risk factor. Inferotemporal breaks were common. Anesthetists were more likely to miss this complication when it occurred. In this series, intervention salvaged vision in a significant number of eyes.

Entities:  

Mesh:

Year:  2007        PMID: 17322598     DOI: 10.4103/0301-4738.30702

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


  12 in total

Review 1.  Corneal neovascularization: an anti-VEGF therapy review.

Authors:  Jin-Hong Chang; Nitin K Garg; Elisa Lunde; Kyu-Yeon Han; Sandeep Jain; Dimitri T Azar
Journal:  Surv Ophthalmol       Date:  2012-09       Impact factor: 6.048

2.  Percaruncular single injection peribulbar anaesthesia in patients with axial myopia for phacoemulsification.

Authors:  Ahmed Samir; Ahmed Gabal
Journal:  Saudi J Ophthalmol       Date:  2011-08-05

3.  Clinical Presentation and Management of Eyes with Globe Perforation during Peribulbar and Retrobulbar Anesthesia: A Retrospective Case Series.

Authors:  Naresh Babu; Jayant Kumar; Piyush Kohli; Ashish Ahuja; Prerana Shah; Kim Ramasamy
Journal:  Korean J Ophthalmol       Date:  2021-11-08

4.  Ophthalmic regional anaesthesia: A review and update.

Authors:  Vv Jaichandran
Journal:  Indian J Anaesth       Date:  2013-01

5.  Management of retinal detachment in block related globe perforation with pneumatic retinopexy.

Authors:  Karandeep Rishi; Pradeep Venkatesh; Satpal P Garg
Journal:  Indian J Ophthalmol       Date:  2013-03       Impact factor: 1.848

6.  Combination of photodynamic therapy with intravitreal bevacizumab for post-peribulbar anesthesia (penetrating trauma)-persistent choroidal neovascular membrane.

Authors:  Nikunj Shah; Urmi Shah
Journal:  Indian J Ophthalmol       Date:  2008 Mar-Apr       Impact factor: 1.848

7.  Management of macular epiretinal membrane secondary to accidental globe perforation during retrobulbar anesthesia.

Authors:  Dhananjay Shukla
Journal:  Indian J Ophthalmol       Date:  2013-05       Impact factor: 1.848

8.  Should single medial canthus injection be the default option for peribulbar blocks?

Authors:  Santhana G Kannan
Journal:  Indian J Anaesth       Date:  2018-04

9.  Swept source optical coherence tomography in globe perforation.

Authors:  Devashish Dubey; Mahesh Shanmugam; Rajesh Ramanjulu; K C Divyansh Mishra; Bindiya Doshi
Journal:  Indian J Ophthalmol       Date:  2019-10       Impact factor: 1.848

10.  ENDOPHTHALMITIS AFTER TRANSCONJUNCTIVAL PARS PLANA VITRECTOMY: A 6-year Experience Without Prophylactic Intraoperative Subconjunctival Antibiotics.

Authors:  Austin L LaGrow; Stephanie N Schatzman; Omar A Amayem; Reagan H Bradford; Vinay A Shah; Sixia Chen; Sun Young Lee
Journal:  Retina       Date:  2021-03-01       Impact factor: 3.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.